Inventor · disambiguated record
Thomas W. Geisbert
Also filed as: GEISBERT THOMAS W · GEISBERT THOMAS WILLIAM
10 granted patents·7 pending applications·293 citations·filing 2006–2023
88Inventor score
Files withPROTIVA BIOTHERAPEUTICS INC3THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND3UNIV TEXAS3GEISBERT THOMAS W2UNIV BOSTON2
Top patents by PatentIndex Score
17 records- 0197US9187748B2Compositions and methods for silencing ebola virus gene expressionPROTIVA BIOTHERAPEUTICS INC·Filed 2014·Granted Nov 17, 2015·93 cites·23 claims
- 0295US7838658B2siRNA silencing of filovirus gene expressionMACLACHLAN IAN·Filed 2006·Granted Nov 23, 2010·181 cites·45 claims
- 0390US8716464B2Compositions and methods for silencing Ebola virus gene expressionGEISBERT THOMAS W·Filed 2010·Granted May 6, 2014·11 cites·20 claims
- 0483US7635485B2Method of accelerated vaccination against Ebola virusesUS HEALTH·Filed 2006·Granted Dec 22, 2009·5 cites·25 claims
- 0581US12358971B2Arena virus monoclonal antibodies and usesTHE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND·Filed 2023·Granted Jul 15, 2025·0 cites·20 claims
- 0678US8017130B2Method of accelerated vaccination against Ebola virusesUS HEALTH·Filed 2009·Granted Sep 13, 2011·2 cites·9 claims
- 0773US8796013B2Pre-or post-exposure treatment for filovirus or arenavirus infectionGEISBERT THOMAS W·Filed 2008·Granted Aug 5, 2014·1 cites·13 claims
- 0868US2011217328A1Compositions and methods for treating ebola virus infectionUNIV BOSTON·Filed 2008·Application pending·0 cites
- 0965US2022089696A1Arenavirus monoclonal antibodies and usesTHE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND·Filed 2021·Application pending·0 cites
- 1057US2014363464A1Pre- or post-exposure treatment for filovirus or arenavirus infectionUNIV BOSTON·Filed 2014·Application pending·0 cites
- 1156US2014255444A1Compositions and methods for treating ebola virus infectionBOSTON MEDICAL CT CORP·Filed 2014·Application pending·0 cites
- 1255US11274282B2Vesicular stomatitis vectors encoding Crimean-Congo hemorrhagic fever antigenUNIV TEXAS·Filed 2020·Granted Mar 15, 2022·0 cites·18 claims
- 1355US11198723B2Arenavirus monoclonal antibodies and usesTHE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND·Filed 2017·Granted Dec 14, 2021·0 cites·13 claims
- 1455US2016264971A1Compositions and methods for silencing ebola virus gene expressionPROTIVA BIOTHERAPEUTICS INC·Filed 2015·Application pending·0 cites
- 1554US2025127878A1Rapid Acting Vaccine Against Nipah VirusUNIV TEXAS·Filed 2022·Application pending·0 cites
- 1647US2011177131A1siRNA SILENCING OF FILOVIRUS GENE EXPRESSIONPROTIVA BIOTHERAPEUTICS INC·Filed 2010·Application pending·0 cites
- 1729US10466231B2Variant angola marburg virusUNIV TEXAS·Filed 2016·Granted Nov 5, 2019·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Thomas W. Geisbert files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →